Adage Capital Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Adage Capital Partners’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-500,000	Closed	-$4.22M	–	754
2015 Q3	$4.22M	Hold	500,000	–	–	0.01%	626
2015 Q2	$4.71M	Hold	500,000	–	–	0.01%	645
2015 Q1	$4.64M	Sell	500,000 -100,000	-17%	-$958K	0.01%	638
2014 Q4	$5.52M	Sell	600,000 -350,000	-37%	-$2.95M	0.01%	614
2014 Q3	$8.47M	Sell	950,000 -182,260	-16%	-$1.33M	0.02%	556
2014 Q2	$8.92M	Hold	1,132,260	–	–	0.02%	547
2014 Q1	$8.97M	Sell	1,132,260 -200,000	-15%	-$1.61M	0.02%	528
2013 Q4	$8.39M	Hold	1,332,260	–	–	0.02%	541
2013 Q3	$4.73M	Hold	1,332,260	–	–	0.01%	596
2013 Q2	$2.6M	Buy	+1,332,260	New	+$2.67M	0.01%	632

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

AIS

AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Adage Capital Partners's CORV Position: Q4 2015 in Review

Adage Capital Partners sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2015, closing a stake of 500,000 shares — an estimated $4.22M sold.

Adage Capital Partners first reported a position in CORV in Q2 2013 and held it in 10 quarters. The position peaked at $8.97M in Q1 2014. 34 funds tracked by Wall St. Rank hold CORV as of Q4 2015.

Adage Capital Partners reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2015 after selling out during the quarter.
Adage Capital Partners sold 500,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2015, an estimated $4.22M.
Adage Capital Partners first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 10 quarters.
Adage Capital Partners's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $8.97M in Q1 2014.
34 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2015.

Based on Adage Capital Partners's 13F filing for Q4 2015, filed 16 Feb 2016.